In Depth Analysis Of Pharmaceutical Pricing Strategies Market

1
Pharmaceutical Pricing Strategies - Changing
approaches to meet challenging times
2
Report Description
The current economic environment has created a
number of challenges within the pharmaceutical
market, with governments looking to reduce
spending on healthcare and drugs. Consequently,
prices have come under scrutiny, with many older
products having discounts forced upon them and
new drugs being subject to increasingly complex
assessments in order to obtain the desired
price. To Get Complete Details Here _at_
http//www.bigmarketresearch.com/pharmaceutical-pr
icing-strategies-changing-approaches-to-meet-chall
enging-times-market Novel pricing policies, such
as value based pricing and external price
referencing, are being employed by governments to
regulate pharmaceutical prices and are expected
to have a significant impact on prices and
profitability in the future.
3
Report Description
The report, Pharmaceutical Pricing Strategies -
Changing approaches to meet challenging times,
uses case study analysis to support companies
with their strategic pricing strategies while
providing insights to aid professionals who are
both new experienced on the subject. This
report will help guide executives focused on the
US and/or the ROW through the growing challenges
in pricing out pharmaceuticals that have taken
shape due to the increasing cost constraints
being experienced in the healthcare systems
across the globe. Enquire About Report_at_
http//www.bigmarketresearch.com/report-enquiry/13
2489 Please Note This product is delivered as a
zip file
4
Report Description

• Scope
• Pricing in pharmaceutical companies - teams and
  activities
• Challenges faced by traditional strategies and
  pricing mechanisms
• Analysis of pricing mechanisms - value-based and
  external reference
• Novel strategies

5
Report Description

• Key Reason To Purchase
• Understand the impact of the economic downturn on
  the pharmaceutical market, including
  cost-containment measures being implemented by
  governments, payers and policy makers.
• Access an overview of the key changes to pricing
  and reimbursement that have occurred in the major
  pharmaceutical markets, along with some of the
  key smaller regional markets
• Understand value-based pricing, including where
  it is currently being used and the potential
  impact of the UK implementing this system
• provides in-depth analysis of novel pricing
  strategies that are currently being used, such as
  risk-share agreements, and whether these
  strategies provide value to payers and
  pharmaceutical companies.
• Receive actionable recommendations about how best
  to implement novel pricing strategies, including
  recommendations for global launch timings and
  factors to consider when deciding the optimum
  indication sequence to maintain price

6
Table Of Content

• Executive summary
• Methodology
• Pricing in pharmaceutical companies
• Teams involved in pricing decisions
• Activities undertaken during pricing decisions
• Pricing pharmaceuticals in a changing environment
• Challenges to the traditional pricing strategies
• Table Of Content_at_ http//www.bigmarketresearch.com
  /pharmaceutical-pricing-strategies-changing-approa
  ches-to-meet-challenging-times-market

7
Table Of Content

• The main pricing mechanisms are changing
• Value-based pricing
• External reference pricing
• Novel strategies being employed
• Risk-share agreements
• Launching without full reimbursement
• Indication sequencing
• Global launch sequencing
• Appendix

8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/pharmaceutical-pr
icing-strategies-changing-approaches-to-meet-chall
enging-times-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_bigmarketresearch.com